These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2145675)

  • 1. Cyclosporine potentiates the in vivo effect of streptozotocin in impairing rat pancreas insulin content.
    Gaja S; Marni A; Ferrero ME
    Transplant Proc; 1990 Oct; 22(5):2250-2. PubMed ID: 2145675
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of the preventive effect of aminobenzoic acid salt on pancreatic islet B cell toxicity by cyclosporine.
    Teraoka S; Kawai T; Yamaguchi Y; Fujita S; Tojinbara T; Nakajima T; Hayashi T; Nakagawa Y; Fujikawa H; Honda H
    Transplant Proc; 1990 Apr; 22(2):863-6. PubMed ID: 2183453
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection by fish oil from cyclosporine-mediated toxicity to the endocrine pancreas.
    Linn T; Zekorn T; Loewk E; Bretzel RG; Federlin K
    Transplant Proc; 1991 Feb; 23(1 Pt 1):326-7. PubMed ID: 1990546
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic and histopathological effects of streptozotocin induced diabetes in rats: effect of propranolol and insulin.
    Bora PS; Srivastava LM; Bhatt SD
    Indian J Exp Biol; 1985 Jan; 23(1):23-6. PubMed ID: 3160657
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation of renal tumorigenicity by cyclosporine A in streptozotocin diabetic rats.
    Reddi AS; Jyothirmayi GN; Halka K; Khan MY
    Cancer Lett; 1991 Feb; 56(2):109-15. PubMed ID: 1825617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine-associated toxicity in pancreatic islet cells and its prevention by K-MAP in cyclosporine-treated animals.
    Teraoka S; Kawai T; Yamaguchi Y; Tojinbara T; Fujita S; Nakajima I; Nakagawa Y; Fujikawa H; Hayashi T; Honda H
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2774-9. PubMed ID: 2650362
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine A toxicity for vascularized pancreatic transplantation in the rat.
    Otsu I; Kitano N; Taminato T; Fujiya H; Nozawa M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1252-6. PubMed ID: 3547858
    [No Abstract]   [Full Text] [Related]  

  • 8. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF; Grose M; Videtic GM; Marliss EB
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological changes in the rat endocrine pancreas within 12 h of intravenous streptozotocin administration.
    Nagasao J; Yoshioka K; Amasaki H; Tsujio M; Ogawa M; Taniguchi K; Mutoh K
    Anat Histol Embryol; 2005 Feb; 34(1):42-7. PubMed ID: 15649226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin.
    Hosokawa M; Dolci W; Thorens B
    Biochem Biophys Res Commun; 2001 Dec; 289(5):1114-7. PubMed ID: 11741307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Previous adaptation to a high-protein diet protects against streptozotocin-induced inhibition of insulin release from isolated rat islets.
    Eizirik DL; Boschero AC; Migliorini RH
    Braz J Med Biol Res; 1985; 18(2):233-5. PubMed ID: 2937500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cyclosporin A on the endocrine pancreas of rats.
    Jablenska R
    Exp Clin Endocrinol; 1989 May; 93(2-3):208-12. PubMed ID: 2673815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifications of the endocrine pancreas in rats after mixed endocrine-exocrine destruction by streptozotocin and ethionine with a protein-free diet.
    Michel C; Chariot J; Souchard M; Rozé C
    Cell Mol Biol; 1986; 32(1):41-54. PubMed ID: 2936454
    [No Abstract]   [Full Text] [Related]  

  • 14. Some characteristics of chemically-induced beta-cell lesions as possible contributing factors in diabetes.
    Grodsky GM; Bolaffi JL
    Adv Exp Med Biol; 1988; 246():339-46. PubMed ID: 2977929
    [No Abstract]   [Full Text] [Related]  

  • 15. Destruction of pancreatic beta cells in rats by complete Freund's adjuvant combined with non-diabetogenic doses of streptozotocin.
    Kohnert KD; Odselius R; Fält K; Ziegler B; Ziegler M; Falkmer S
    Diabetes Res; 1987 May; 5(1):1-11. PubMed ID: 2957141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma glucose and pancreatic insulin content in the early phase of streptozotocin-induced diabetes (preliminary results).
    Hahn HJ; Hagen R; Knobloch C; Besch W
    Acta Biol Med Ger; 1981; 40(1):83-5. PubMed ID: 6455026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of cyclosporin on exocrine and endocrine functions of the rat pancreas.
    Suzuki S; Oka T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):913-4. PubMed ID: 2468229
    [No Abstract]   [Full Text] [Related]  

  • 18. Functional and morphological study of cultured pancreatic islets treated with cyclosporine.
    Ajabnoor MA; El-Naggar MM; Elayat AA; Abdulrafee A
    Life Sci; 2007 Jan; 80(4):345-55. PubMed ID: 17074365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptozotocin treatment at birth induces a parallel depletion of thyrotropin-releasing hormone and insulin in the rat pancreas during development.
    Aratan-Spire S; Wolf B; Portha B; Bailbe D; Czernichow P
    Endocrinology; 1984 Jun; 114(6):2369-73. PubMed ID: 6233134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.